Academic research has long been characterized by silos and protective instincts.

How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.

In light of advancing fetal diagnostic capabilities, a team of U-M physicians is working to improve the decision-making process for families facing complex decisions about their unborn child’s care.

Not all children with epilepsy have access to specialized care and may risk serious and far-reaching side effects. U-M is leading a collaborative to change this situation.

A multidisciplinary meeting at Mott elevates pediatric cancer cases to dozens of experts. A new review finds it’s improving care and comforting families in the process.

U-M researchers are investigating a new immunotherapy drug for AML in children — one with a built-in "safety switch" in case unexpected adverse reactions occur.